Assays are used in a diverse range of fields within the life sciences, and have become routine work in forensic, pharmaceutical, and microbiology labs. When designing an assay for any purpose, the ...
Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...
Please provide your email address to receive an email when new articles are posted on . A novel assay may help direct antibody-drug conjugate therapy through measurements of HER2 and TROP2. Most ...
Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...
In this roundtable webinar, discover how scientists improve tumor-informed minimal residual disease (MRD) testing for ...
The recurrence score based on the 21-gene breast-cancer assay has been clinically useful in predicting a chemotherapy benefit in hormone-receptor–positive, human epidermal growth factor receptor 2 ...
Axion BioSystems’ Letter of Intent for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular ...
Zacks Investment Research on MSN
NeoGenomics announces launch of new cancer assay PanTracer Pro
NeoGenomics, Inc. NEO recently announced the availability of its new pan-solid tumor assay, PanTracer Pro, designed to help clinicians navigate increasingly complex molecular testing workflows to make ...
FDA grants Breakthrough Device Designation to BioAgilytix’s anti-AAV antibody assay supporting Lexeo’s gene therapy for ...
Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results